Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Calgary
$27,000.00
A New Approach to Alzheimer’s Disease: Astrocyte to Oligodendrocyte Reprogramming
EF 2025-26
Résumé
Alzheimer's disease causes memory loss and thinking problems, affecting millions worldwide. Although it is very common, there is still no cure. Most treatments have focused on targeting the toxic proteins found in the brains of people with Alzheimer’s, however these approaches have not been successful in stopping the disease or restoring lost abilities. Recent discoveries show that support cells in the brain (astrocytes and oligodendrocytes) play major roles in Alzheimer’s. Astrocytes worsen inflammation, while the loss of oligodendrocytes slows down information transmission by neurons. Our research explores an innovative approach called direct lineage reprogramming, which converts astrocytes, which have become unhealthy due to the disease, into new oligodendrocytes to promote brain repair.
Previous work in our lab has shown successful conversion between these cell types in mice. However, because human and mouse brain cells differ significantly, therapies that work in mice often fail in people. To overcome this challenge, we will grow human astrocytes and then test whether reprogramming can convert these human astrocytes into oligodendrocytes. Importantly, we will also assess whether this approach can repair the harmful changes that occur in Alzheimer’s disease.
The discovery that reprogramming human brain cells can repair damage caused by Alzheimer’s disease would represent a major break-through in disease treatment. Reprogramming would represent a regenerative treatment that can actually restore brain function instead of just slowing down disease progression. Beyond Alzheimer’s disease, this approach could also benefit many other neurological conditions, offering new hope to millions of patients worldwide.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
573143
Name
de Witte Ashley S
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A New Approach to Alzheimer’s Disease: Astrocyte to Oligodendrocyte Reprogramming
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Alzheimer'S Disease; Astrocytes; Direct Lineage Reprogramming; Human Pluripotent Stem Cells; Oligodendrocytes; Regenerative Medicine; Translational Research
Abstract
Alzheimer's disease causes memory loss and thinking problems, affecting millions worldwide. Although it is very common, there is still no cure. Most treatments have focused on targeting the toxic proteins found in the brains of people with Alzheimer’s, however these approaches have not been successful in stopping the disease or restoring lost abilities. Recent discoveries show that support cells in the brain (astrocytes and oligodendrocytes) play major roles in Alzheimer’s. Astrocytes worsen inflammation, while the loss of oligodendrocytes slows down information transmission by neurons. Our research explores an innovative approach called direct lineage reprogramming, which converts astrocytes, which have become unhealthy due to the disease, into new oligodendrocytes to promote brain repair.
Previous work in our lab has shown successful conversion between these cell types in mice. However, because human and mouse brain cells differ significantly, therapies that work in mice often fail in people. To overcome this challenge, we will grow human astrocytes and then test whether reprogramming can convert these human astrocytes into oligodendrocytes. Importantly, we will also assess whether this approach can repair the harmful changes that occur in Alzheimer’s disease.
The discovery that reprogramming human brain cells can repair damage caused by Alzheimer’s disease would represent a major break-through in disease treatment. Reprogramming would represent a regenerative treatment that can actually restore brain function instead of just slowing down disease progression. Beyond Alzheimer’s disease, this approach could also benefit many other neurological conditions, offering new hope to millions of patients worldwide.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
de Witte, Ashley S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~